Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions
Clinical trial NCT04729998 · UNKNOWN
Trial details
- NCT number
- NCT04729998
- Sponsor
- Pharmtechnology LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-30
- Primary completion
- 2021-02-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.